These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 33811680)

  • 1. Downregulation of type III interferons in patients with severe COVID-19.
    Fukuda Y; Homma T; Inoue H; Onitsuka C; Ikeda H; Goto Y; Sato Y; Kimura T; Hirai K; Ohta S; Yamamoto M; Kusumoto S; Suzuki S; Tanaka A; Sagara H
    J Med Virol; 2021 Jul; 93(7):4559-4563. PubMed ID: 33811680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basic Predictive Risk Factors for Cytokine Storms in COVID-19 Patients.
    Shcherbak SG; Anisenkova AY; Mosenko SV; Glotov OS; Chernov AN; Apalko SV; Urazov SP; Garbuzov EY; Khobotnikov DN; Klitsenko OA; Minina EM; Asaulenko ZP
    Front Immunol; 2021; 12():745515. PubMed ID: 34858403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum IL-28A/IFN-λ2 is linked to disease severity of COVID-19.
    Fukuda Y; Homma T; Inoue H; Goto Y; Sato Y; Ikeda H; Onitsuka C; Sato H; Akimoto K; Ebato T; Suganuma H; Kawahara T; Mikuni H; Uchida Y; Suzuki S; Tanaka A; Sagara H
    Sci Rep; 2022 Mar; 12(1):5458. PubMed ID: 35361913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linkage of Lambda Interferons in Protection Against Severe COVID-19.
    Shahbazi M; Amri Maleh P; Bagherzadeh M; Moulana Z; Sepidarkish M; Rezanejad M; Mirzakhani M; Ebrahimpour S; Ghorbani H; Ahmadnia Z; Javanian M; Bayani M; Mohammadnia-Afrouzi M
    J Interferon Cytokine Res; 2021 Apr; 41(4):149-152. PubMed ID: 33885337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inflammatory markers of multisystem inflammatory syndrome in children (MIS-C) and adolescents associated with COVID-19: A meta-analysis.
    Zhao Y; Yin L; Patel J; Tang L; Huang Y
    J Med Virol; 2021 Jul; 93(7):4358-4369. PubMed ID: 33739452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of Association of Infection-related Biomarkers and Inflammatory Cytokines with the Severity of Coronavirus Disease 2019: A Prospective Observational Study.
    Injarapu RK; Tamboli A; Shah L; Phalgune D
    J Assoc Physicians India; 2024 Aug; 72(8):44-47. PubMed ID: 39163062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation?
    Vaira LA; De Vito A; Deiana G; Pes C; Giovanditto F; Fiore V; Lechien JR; Saussez S; Policicchio D; Boccaletti R; Madeddu G; Babudieri S; Pazzola A; Bandiera F; Fois AG; Piana AF; Hopkins C; De Riu G
    J Laryngol Otol; 2021 Aug; 135(8):723-728. PubMed ID: 34184623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFN Lambda Deficiency Contributes to Severe COVID-19 Outcomes.
    Zaleska A; Dor-Wojnarowska A; Radlińska A; Rorat M; Szymański W; Gajewski A; Chałubiński M
    Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analyzing Correlation of Clinical Severity of COVID-19 with Other Biochemical Parameters: A Retrospective Study from Pakistan.
    Hassan Shah SST; Naeem I; Wahid B
    Tohoku J Exp Med; 2021 Dec; 255(4):315-323. PubMed ID: 34911879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Hb A
    Unluguzel Ustun G; Keskin A; Aci R; Arslanbek Erdem M; Ari M
    Hemoglobin; 2021 Mar; 45(2):124-128. PubMed ID: 34162301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil-to-lymphocyte ratio, a critical predictor for assessment of disease severity in patients with COVID-19.
    Liu L; Zheng Y; Cai L; Wu W; Tang S; Ding Y; Liu W; Kou G; Xiong Z; Wang S; Zheng S
    Int J Lab Hematol; 2021 Apr; 43(2):329-335. PubMed ID: 33099889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual classification of three computed tomography lung patterns to predict prognosis of COVID-19: a retrospective study.
    Yamada D; Ohde S; Imai R; Ikejima K; Matsusako M; Kurihara Y
    BMC Pulm Med; 2022 Jan; 22(1):1. PubMed ID: 34980061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type I, II, and III Interferon Signatures Correspond to Coronavirus Disease 2019 Severity.
    Kim MH; Salloum S; Wang JY; Wong LP; Regan J; Lefteri K; Manickas-Hill Z; Gao C; Li JZ; Sadreyev RI; Yu XG; Chung RT;
    J Infect Dis; 2021 Sep; 224(5):777-782. PubMed ID: 34467988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 in Children: Expressions of Type I/II/III Interferons, TRIM28, SETDB1, and Endogenous Retroviruses in Mild and Severe Cases.
    Tovo PA; Garazzino S; Daprà V; Pruccoli G; Calvi C; Mignone F; Alliaudi C; Denina M; Scolfaro C; Zoppo M; Licciardi F; Ramenghi U; Galliano I; Bergallo M
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inflammatory biomarkers profile of hospitalized patients with COVID-19 and its association with patient's outcome: A single centered study.
    Hachim IY; Hachim MY; Hannawi H; Naeem KB; Salah A; Hannawi S
    PLoS One; 2021; 16(12):e0260537. PubMed ID: 34855832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Diagnostic Efficacies of Serological Markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in Idiopathic Interstitial Pneumonia.
    Xue M; Guo Z; Cai C; Sun B; Wang H
    Respiration; 2019; 98(6):534-545. PubMed ID: 31665737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unveiling Immunological and Hematological Markers in COVID-19: Insights from a Clinical Study.
    Imran H; Aqeel MB; Gull S; Saleem F; Khan Z
    Viral Immunol; 2024 Oct; 37(8):411-418. PubMed ID: 39356231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of inflammatory biomarkers in patients with COVID-19 infections: Bahrain experience.
    Farid E; Sridharan K; Alsegai OA; Khawaja SA; Mansoor EJ; Teraifi NA; Qahtani MA; Salman JA
    Biomark Med; 2021 Jun; 15(8):541-549. PubMed ID: 33988463
    [No Abstract]   [Full Text] [Related]  

  • 19. Predictors of disease severity and outcome of hospitalized renal transplant recipients with COVID-19 infection: a systematic review of a globally representative sample.
    Hasan I; Rashid T; Suliman S; Amer H; Chirila RM; Mai ML; Jarmi T; Khouzam S; Franco PM; Heilig CW; Wadei HM
    Rom J Intern Med; 2021 Mar; 59(1):10-42. PubMed ID: 33155999
    [No Abstract]   [Full Text] [Related]  

  • 20. Determinants of severity among hospitalised COVID-19 patients: Hospital-based case-control study, India, 2020.
    Zodpey SP; Negandhi H; Kamal VK; Bhatnagar T; Ganeshkumar P; Athavale A; Kadri A; Patel A; Bhagyalaxmi A; Khismatrao D; Theranirajan E; Banumathi G; Singh K; Parameshwari P; Kshirsagar P; Saxena R; Deshpande SG; Satyanand K; Hadke S; Dube S; Subramaniam S; Madan S; Kadam S; Anand T; Jeyashree K; Ponnaiah M; Rana M; Murhekar MV; Reddy D
    PLoS One; 2021; 16(12):e0261529. PubMed ID: 34965276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.